Remind me, was it late 2016, or in 2017 that Pravin Kaumaya entrusted his brilliant drug technology to Imugene to trial, and then bring to market?
I had a peep at the IMU 2013 AGM Report which contained the forecast for the Phase 3 trial commencement of HERR-vaxx in 2015, with commercialisation in 2016! I do remember my decision to invest in IMU was predicated on the success of the drug in the Phase 1 trial for breast cancer. I think we may have owned the 2 drugs for a combined 17 years now!!
Media Thread, page-11153
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 877572 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |